Nyrada Inc. (ASX:NYR)

Australia · Delayed Price · Currency is AUD

0.5600

+0.0050 (0.90%)

May 8, 2026, 3:55 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018
Drug Development, Focusing on Small Molecules	2.40M	3.24M	1.43M	1.09M	2.34M
Drug Development, Focusing on Small Molecules Growth	-26.07%	126.72%	30.73%	-53.18%	107.57%
Total	2.40M	3.24M	1.43M	1.09M	2.34M
Total Growth	-26.07%	126.72%	30.73%	-53.18%	107.57%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018
Australasia	2.40M	3.24M	1.43M	1.09M	2.34M
Australasia Growth	-26.07%	126.72%	30.73%	-53.18%	107.57%
Total	2.40M	3.24M	1.43M	1.09M	2.34M
Total Growth	-26.07%	126.72%	30.73%	-53.18%	107.57%

Source: S&P Global Market Intelligence.